Showing results (401-410 of 557) with videos related to

Sort By:
Pageof 56
Chemical & Pharmaceutical Bulletin|April 6, 2007
Alpha-substituted 1-aryl-3-dimethylaminopropanone hydrochlorides: potent cytotoxins towards human WiDr colon cancer cellsHari Narayan Pati, Umashankar Das, Irving Javier Ramirez-Erosa, et al.
Bioorganic & Medicinal Chemistry|April 14, 2016
Tumour-specific cytotoxicity and structure-activity relationships of novel 1-[3-(2-methoxyethylthio)propionyl]-3,5-bis(benzylidene)-4-piperidonesMohammad Hossain, Umashankar Das, Naoki Umemura, et al.
Indian Heart Journal|February 26, 2009
Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID studyBalram Bhargava, Ganesan Karthikeyan, Pr Bhima Shankar, et al.
Bioorganic & Medicinal Chemistry Letters|January 13, 2010
3,5-Bis(benzylidene)-1-[4-2-(morpholin-4-yl)ethoxyphenylcarbonyl]-4-piperidone hydrochloride: a lead tumor-specific cytotoxin which induces apoptosis and autophagyUmashankar Das, Hiroshi Sakagami, Qing Chu, et al.
Bioinformatics (Oxford, England)|August 13, 2010
MetDAT: a modular and workflow-based free online pipeline for mass spectrometry data processing, analysis and interpretationAmbarish Biswas, Kalyan C Mynampati, Shivshankar Umashankar, et al.
Bulletin of the World Health Organization|March 28, 2008
Cost and effectiveness analysis of immunization service delivery support in Andhra Pradesh, IndiaChutima Suraratdecha, Cbs Venkata Ramana, Satish Kaipilyawar, et al.
Chemical & Pharmaceutical Bulletin|December 2, 2008
Synthesis and cytotoxicity of novel 3-aryl-1-(3'-dibenzylaminomethyl-4'-hydroxyphenyl)-propenones and related compoundsHalise Inci Gul, Kadir Ozden Yerdelen, Umashankar Das, et al.
Critical Care (London, England)|May 27, 2024
A scoping review of machine learning for sepsis prediction- feature engineering strategies and model performance: a step towards explainabilitySherali Bomrah, Mohy Uddin, Umashankar Upadhyay, et al.
BMC Gastroenterology|September 17, 2024
Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARYNoa Krugliak Cleveland, Sabyasachi Ghosh, Benjamin Chastek, et al.
Archiv Der Pharmazie|February 15, 2011
The design and cytotoxic evaluation of some 1-aryl-3-isopropylamino-1-propanone hydrochlorides towards human Huh-7 hepatoma cellsEbru Mete, H Inci Gul, Rengul Cetin-Atalay, et al.
Pageof 56